A comprehensive view of Metabolic Disorders. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.
AstraZeneca reports Q1 revenue up 17% year-over-year to US$12.7B, operating profit up 22% to US$3.1B, with oncology sales growing 23% YoY to US$5.1B, metabolic and cardiovascular drug sales increasing 20% YoY to US$3.1B; annual guidance remains unchanged
Published:
April 25, 2024
by BioPharma Dive
|
US Patent Issued to Pfizer on April 23 for "Heteroaromatic compounds and their use as dopamine D1 ligands" (Massachusetts, Connecticut, Colorado Inventors)
Published:
April 24, 2024
by U.S. Fed News
|
US Patent Issued to Novartis on April 23 for "Methods of treating HIV-HAART induced partial lipodystrophy with FGF21 protein variant FC fusion proteins" (Massachusetts Inventors)
Published:
April 24, 2024
by U.S. Fed News
|
INTERNATIONAL PATENT: THE BROAD INSTITUTE, INC., BIOGEN MA INC. FILES APPLICATION FOR "GLYCOGEN SYNTHASE KINASE 3 INHIBITORS AND USES THEREOF"
Published:
April 23, 2024
by U.S. Fed News
|
INTERNATIONAL PATENT: THE GENERAL HOSPITAL CORPORATION, MASSACHUSETTS EYE AND EAR INFIRMARY, BANNER HEALTH FILES APPLICATION FOR "COMPOSITIONS AND METHODS USING REELIN IN ALZHEIMER'S DISEASE"
Published:
April 23, 2024
by U.S. Fed News
|
Ask us about our Consumer Wellness market view